Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Income from Non-Controlling Interests (2016 - 2018)

IGC Pharma (IGC) has disclosed Income from Non-Controlling Interests for 9 consecutive years, with $634.0 as the latest value for Q1 2018.

  • Quarterly Income from Non-Controlling Interests rose 105.09% to $634.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $320.0 through Jun 2018, down 98.42% year-over-year, with the annual reading at $14399.0 for FY2017, 156.02% up from the prior year.
  • Income from Non-Controlling Interests for Q1 2018 was $634.0 at IGC Pharma, up from -$230.0 in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $38088.0 in Q4 2016, with the low at -$42000.0 in Q4 2015.
  • Average Income from Non-Controlling Interests over 5 years is -$3364.4, with a median of -$5073.0 recorded in 2016.
  • The sharpest move saw Income from Non-Controlling Interests plummeted 15820.44% in 2014, then surged 450.89% in 2015.
  • Over 5 years, Income from Non-Controlling Interests stood at -$8882.0 in 2014, then tumbled by 372.87% to -$42000.0 in 2015, then soared by 190.69% to $38088.0 in 2016, then tumbled by 100.6% to -$230.0 in 2017, then surged by 375.65% to $634.0 in 2018.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $634.0, -$230.0, and -$84.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.